Revolution Medicines, Inc. ( RVMD) - Key Metrics
RVMD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$1.92 | -$1.44 | -$1.45 |
| 2025Q3 | ? | -$1.61 | -$1.10 | -$1.11 |
| 2025Q2 | ? | -$1.32 | -$1.18 | -$1.22 |
| 2025Q1 | ? | -$1.13 | -$1.03 | -$1.05 |
RVMD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -10.38 |
| 2025Q3 | ? | -7.24 |
| 2025Q2 | ? | -6.98 |
| 2025Q1 | ? | -7.79 |
RVMD
Price: $153.87
52 week price:
Earnings Per Share: -7.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 856800
Market Capitalization: 32.2 billion